2,537 results on '"endocrine gland neoplasms"'
Search Results
2. Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
3. Familial Investigations of Childhood Cancer Predisposition (SJFAMILY)
4. Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
5. Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
6. Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
7. Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
8. Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2
9. Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
10. Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. (BANN)
11. Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
12. OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (OSPREY)
13. First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
14. Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death (SuddenDeath)
15. Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (ARROW)
16. Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
17. Early Check: Expanded Screening in Newborns
18. Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region. (AURA-RIV-TNE)
19. Symptom Management for YA Cancer Survivors
20. Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
21. Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
22. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)
23. Asymptomatic Small Pancreatic Endocrine Neoplasms. (ASPEN)
24. A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
25. SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
26. CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
27. Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients (PRIME)
28. The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
29. Study and Monitoring of Multiple Endocrine Neoplasia Type 1 (NEM)
30. Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
31. Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
32. Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
33. A Research Registry on Aggressive PitNETs (RECAPitNETT)
34. Cryoablation of Bone Metastases From Endocrine Tumors
35. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (apact)
36. Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET (ReLUTH)
37. Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN)
38. A Retrospective Study for Multiple Endocrine Neoplasia
39. Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
40. Establishment of a Tumor Bank for Tissue Samples
41. Establishment of a Tumor Bank for Blood Samples
42. Diagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs
43. N-Nitrosomorpholine-induced oncocytic transformation in rat endocrine organs
44. Studies of Inherited Diseases of Metabolism
45. Spanish Series of Patients Treated With the Radionuclide Lutetium177 (SEPTRALU)
46. Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases (LUTIA)
47. N-Nitrosomorpholine-induced oncocytic transformation in rat endocrine organs.
48. Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour (NET729)
49. Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours (CLARINET)
50. EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.